Neither imatinib nor sunitinib treatment influenced TGFB1 mRNA expression (Supplementary Fig. S2c), suggesting that tyrosine kinase-mediated signaling in GIST cells did not affect TGF-β1 expression. This evidence concerns the gene TGFB1 and gastrointestinal stromal tumor.